KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2013 / Cilt: 43 - Sayı: 3

The correlation between metabolic syndrome and lower urinary tract symptoms in females

Cevdet Serkan GÖKKAYA
Cüneyt ÖZDEN
Binhan Kağan AKTAŞ
Hüseyin Cihan DEMİREL
Özer GÜZEL
Mehmet KARABAKAN
Akif Ersoy ERKMEN
Çetin Volkan ÖZTEKİN
Ali MEMİŞ
Sayfa
400–404
Yayın Tarihi
2013-03-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The results of our study have shown that women with more than 3 MS components might have more storage symptoms than women without MS.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:To evaluate the association between lower urinary tract symptoms (LUTS) and metabolic syndrome (MS) in women.
📊
Temel Bulgular & Veri:Materials and methods: A total of 155 women with LUTS were included in the study.
💡
Sonuç & Katkı:Conclusion: The results of our study have shown that women with more than 3 MS components might have more storage symptoms than women without MS.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Key words: Female · lower urinary tract symptoms · metabolic syndrome

Özet

To evaluate the association between lower urinary tract symptoms (LUTS) and metabolic syndrome (MS) in women. Materials and methods: A total of 155 women with LUTS were included in the study. LUTS were evaluated using the International Prostate Symptom Score (IPSS) and the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire. Besides total IPSS, voiding and storage IPSS were calculated separately. Diagnosis of MS was made according to the consensus report of the International Diabetes Foundation. The patients were classified into 3 groups: those without MS (group 1), those with 3 risk factors of MS (group 2), and those with more than 3 risk factors of MS (group 3). The groups were compared regarding IPSS and BFLUTS data. Results: Of the patients, 37.4% (n = 58) had MS, while 62.6% (n = 97) did not. There were significant differences between group 1 and group 3 regarding BFLUTS-FS (filling symptoms), BFLUTS-QoL (quality of life), storage IPSS, and total IPSS. However, concerning BFLUTS-VS (voiding symptoms), BFLUTS-sex, and voiding IPSS, there was not any difference among the 3 groups. Conclusion: The results of our study have shown that women with more than 3 MS components might have more storage symptoms than women without MS.

Abstract

To evaluate the association between lower urinary tract symptoms (LUTS) and metabolic syndrome (MS) in women. Materials and methods: A total of 155 women with LUTS were included in the study. LUTS were evaluated using the International Prostate Symptom Score (IPSS) and the Bristol Female Lower Urinary Tract Symptoms (BFLUTS) questionnaire. Besides total IPSS, voiding and storage IPSS were calculated separately. Diagnosis of MS was made according to the consensus report of the International Diabetes Foundation. The patients were classified into 3 groups: those without MS (group 1), those with 3 risk factors of MS (group 2), and those with more than 3 risk factors of MS (group 3). The groups were compared regarding IPSS and BFLUTS data. Results: Of the patients, 37.4% (n = 58) had MS, while 62.6% (n = 97) did not. There were significant differences between group 1 and group 3 regarding BFLUTS-FS (filling symptoms), BFLUTS-QoL (quality of life), storage IPSS, and total IPSS. However, concerning BFLUTS-VS (voiding symptoms), BFLUTS-sex, and voiding IPSS, there was not any difference among the 3 groups. Conclusion: The results of our study have shown that women with more than 3 MS components might have more storage symptoms than women without MS.

🔖

Bu Makaleye Atıf Yap

GÖKKAYA, C. S., ÖZDEN, C., AKTAŞ, B. K., DEMİREL, H. C., GÜZEL, Ö., KARABAKAN, M., ERKMEN, A. E., ÖZTEKİN, Ç. V., MEMİŞ, A. (2013). The correlation between metabolic syndrome and lower urinary tract symptoms in females. Turkish Journal of Medical Sciences, Cilt: 43 - Sayı: 3, 400–404. https://ajindex.com/articles/406585

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D’Agostino RB Sr, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007; 30: 1219–25.
  2. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066–72.
  3. Ayvaz DNÇ, Kılınç FN, Paç FA, Çakal E. Anthropometric measurements and body composition analysis of obese adolescents with and without metabolic syndrome. Turk J Med Sci 2011; 41: 267–74.
  4. Ecemiş GC, Kahraman H, Nural MS, Aslan HS, Atmaca A. The relationship between insulin resistance and carotid artery intima-media thickness in obese and morbidly obese women. Turk J Med Sci 2012; 42: 1121–8.
  5. Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens 2008; 26: 2064–70.
  6. Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A et al. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord 2009; 7: 427–34.
  7. Fox CS, Massaro JM, Hoffmann U, Pou KM, MaurovichHorvat P, Liu CY et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39– Akkiprik M, Sertoğlu FÖ, Çağlayan S, Aral C, Özışık G, Atabey Z et al. Association of ACP1 genotypes and clinical parameters in patients with metabolic syndrome. Turk J Med Sci 2011; 41: 533–41.
  8. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–9.
  9. Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels a prospective and crosssectional evaluation. Atherosclerosis 2002; 165: 285–92. Gammack JK. Lower urinary tract symptoms. Clin Geriatr Med 2010; 26: 249–60.
  10. Fultz NH, Herzog AR. Epidemiology of urinary symptoms in the geriatric population. Urol Clin North Am 1996; 23: 1–10.
  11. Alexander CM, Landsman PB, Grundy SM. The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab 200